Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of olprinone injection in acute heart failure
ChiCTR2200055129Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of olprinone in Acute Heart Failure (AHF), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: B-type natriuretic peptide/N-terminal pro-B-type natriuretic peptide. Started Oct 2021; status: recruiting.
02
Drugs
olprinone
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2200055129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055129.